{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T17:00:06Z","timestamp":1780678806006,"version":"3.54.1"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"16","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4,17]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Matrix metalloproteinases (MMPs) have been implicated in the pathogenesis of interstitial lung disease (ILD). However, the causal role of MMPs in ILD pathogenesis remains to be elucidated. This study aimed to investigate the causal effects of circulating MMPs on ILD risk and to evaluate whether immune cell phenotypes mediate this relationship. A comprehensive Mendelian randomization (MR) and mediation analysis was conducted using publicly available data of genome-wide association study (GWAS) summary statistics. Genetic instruments for 6 MMPs (MMP-1, MMP-2, MMP-3, MMP-7, MMP-9, and MMP-12) and 731 immune cell traits were selected. Inverse-variance weighted (IVW) was the primary analytical method, supplemented by other MR techniques. Sensitivity analyses included MR-Egger regression, Cochran\n                      <jats:italic toggle=\"yes\">Q<\/jats:italic>\n                      test, and MR-PRESSO to assess pleiotropy and heterogeneity. Mediation analysis was performed to quantify the proportion of the effect mediated by significant immune cells. Genetically predicted MMP-9 levels showed a significant positive causal effect on ILD risk (odds ratio [OR]\u2005=\u20051.034, 95% confidence interval [CI]: 1.006\u20131.064,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.018). Among 731 immune cell phenotypes, 8 were identified as causal for ILD, including effector memory double negative T cells (EM DNT; OR\u2005=\u20051.170,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.001). MMP-9 was further found to increase the abundance of EM DNT (OR\u2005=\u20051.041, 95% CI: 1.009\u20131.074,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.012). Mediation analysis indicated that EM DNT mediated 18.5% of the total effect of MMP-9 on ILD. Sensitivity analyses revealed no evidence of horizontal pleiotropy or significant heterogeneity. This study provides genetic evidence supporting a causal role of MMP-9 in the development of ILD, partially mediated through EM DNT. These findings suggest that MMP-9 and EM DNT could be potential therapeutic targets for preventing or treating ILD.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000048305","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T14:02:10Z","timestamp":1776434530000},"page":"e48305","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The causal effect of matrix metalloproteinase 9 on interstitial lung disease risk mediated by effector memory double negative T cells: A mediation Mendelian randomization study"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6976-9032","authenticated-orcid":false,"given":"Qijie","family":"Ren","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Immunology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyuan","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7664-8776","authenticated-orcid":false,"given":"Leilei","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8573-3275","authenticated-orcid":false,"given":"Dinglei","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minning","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260605","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(22)01052-2","article-title":"Interstitial lung diseases.","volume":"400","author":"Wijsenbeek","year":"2022","journal-title":"Lancet"},{"key":"R2-20260605","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra1705751","article-title":"Idiopathic pulmonary fibrosis.","volume":"378","author":"Lederer","year":"2018","journal-title":"N Engl J Med"},{"key":"R3-20260605","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.rmed.2018.12.015","article-title":"Inflammation and immunity in IPF pathogenesis and treatment.","volume":"147","author":"Heukels","year":"2019","journal-title":"Respir Med"},{"key":"R4-20260605","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s10020-025-01128-2","article-title":"Matrix metalloproteinases and their tissue inhibitors as upcoming biomarker signatures of connective tissue diseases-related interstitial lung disease: towards an earlier and accurate diagnosis.","volume":"31","author":"Pulito-Cueto","year":"2025","journal-title":"Mol Med"},{"key":"R5-20260605","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/art.42812","article-title":"Plasma matrix metalloproteinase concentrations and risk of interstitial lung disease in a prospective rheumatoid arthritis cohort.","volume":"76","author":"Luedders","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"R6-20260605","doi-asserted-by":"crossref","first-page":"116116","DOI":"10.1016\/j.biopha.2023.116116","article-title":"The role of matrix metalloproteinase 9 in fibrosis diseases and its molecular mechanisms.","volume":"171","author":"Wang","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"R7-20260605","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1016\/j.cell.2024.05.015","article-title":"Immune mechanisms in fibrotic interstitial lung disease.","volume":"187","author":"Kamiya","year":"2024","journal-title":"Cell"},{"key":"R8-20260605","doi-asserted-by":"crossref","first-page":"1569501","DOI":"10.3389\/fimmu.2025.1569501","article-title":"Breaking the cycle: should we target inflammation, fibrosis, or both?","volume":"16","author":"Baxter","year":"2025","journal-title":"Front Immunol"},{"key":"R9-20260605","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1146\/annurev-immunol-103019-085803","article-title":"In vivo CD4+ T cell differentiation and function: revisiting the Th1\/Th2 paradigm.","volume":"38","author":"Ruterbusch","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"R10-20260605","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement.","volume":"326","author":"Skrivankova","year":"2021","journal-title":"JAMA"},{"key":"R11-20260605","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/thorax-2024-221472","article-title":"Assessing causal relationships between diabetes mellitus and idiopathic pulmonary fibrosis: a Mendelian randomisation study.","volume":"80","author":"Moss","year":"2025","journal-title":"Thorax"},{"key":"R12-20260605","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1186\/s12931-024-03008-5","article-title":"Plasma genome-wide Mendelian randomization identifies potentially causal genes in idiopathic pulmonary fibrosis.","volume":"25","author":"Zhang","year":"2024","journal-title":"Respir Res"},{"key":"R13-20260605","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s41588-020-0684-4","article-title":"Complex genetic signatures in immune cells underlie autoimmunity and inform therapy.","volume":"52","author":"Orr\u00f9","year":"2020","journal-title":"Nat Genet"},{"key":"R14-20260605","doi-asserted-by":"crossref","first-page":"e46693","DOI":"10.1097\/MD.0000000000046693","article-title":"Unraveling the causal link between immune cells and temporomandibular disorders: a Mendelian randomization analysis.","volume":"104","author":"Zhang","year":"2025","journal-title":"Medicine (Baltim)"},{"key":"R15-20260605","doi-asserted-by":"crossref","first-page":"1326344","DOI":"10.3389\/fendo.2023.1326344","article-title":"Causal association of immune cells and polycystic ovarian syndrome: a Mendelian randomization study.","volume":"14","author":"Aru","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R16-20260605","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s12890-023-02589-z","article-title":"Vitamin D and idiopathic pulmonary fibrosis: a two-sample Mendelian randomization study.","volume":"23","author":"Lin","year":"2023","journal-title":"BMC Pulm Med"},{"key":"R17-20260605","doi-asserted-by":"crossref","first-page":"6894","DOI":"10.3390\/ijms23136894","article-title":"Matrix metalloproteinases and their inhibitors in pulmonary fibrosis: EMMPRIN\/CD147 comes into play.","volume":"23","author":"Chuli\u00e1-Peris","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R18-20260605","doi-asserted-by":"crossref","first-page":"104591","DOI":"10.1016\/j.phrs.2019.104591","article-title":"Matrix metalloproteinase: an upcoming therapeutic approach for idiopathic pulmonary fibrosis.","volume":"152","author":"Mahalanobish","year":"2020","journal-title":"Pharmacol Res"},{"key":"R19-20260605","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1016\/j.biocel.2007.06.022","article-title":"Overexpression of MMP9 in macrophages attenuates pulmonary fibrosis induced by bleomycin.","volume":"39","author":"Cabrera","year":"2007","journal-title":"Int J Biochem Cell Biol"},{"key":"R20-20260605","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/imm.13441","article-title":"Double-negative T cells: setting the stage for disease control or progression.","volume":"165","author":"Velikkakam","year":"2022","journal-title":"Immunology"},{"key":"R21-20260605","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/BOR.0000000000000778","article-title":"Double-negative T cells in autoimmune diseases.","volume":"33","author":"Li","year":"2021","journal-title":"Curr Opin Rheumatol"},{"key":"R22-20260605","doi-asserted-by":"crossref","first-page":"816005","DOI":"10.3389\/fimmu.2022.816005","article-title":"CD3+CD4-CD8- (double-negative) T cells in inflammation, immune disorders and cancer.","volume":"13","author":"Wu","year":"2022","journal-title":"Front Immunol"},{"key":"R23-20260605","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1016\/j.jtcvs.2019.09.188","article-title":"CD3+CD4-CD8- Double-negative \u03b1\u03b2 T cells attenuate lung ischemia-reperfusion injury.","volume":"161","author":"Hsu","year":"2021","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R24-20260605","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/mi.2015.91","article-title":"Double-negative T resident memory cells of the lung react to influenza virus infection via CD11c(hi) dendritic cells.","volume":"9","author":"Neyt","year":"2016","journal-title":"Mucosal Immunol"},{"key":"R25-20260605","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.immuni.2018.02.010","article-title":"Understanding subset diversity in T cell memory.","volume":"48","author":"Jameson","year":"2018","journal-title":"Immunity"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048305","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T16:01:34Z","timestamp":1780675294000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":25,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048305","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"2025-10-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}